EVALUATING THE IMPACT OF MODERN ANTI-DIABETIC DRUGS ON SURVIVAL OUTCOMES IN LUNG CANCER PATIENTS WITH TYPE 2 DIABETES. JMHSR [Internet]. 2025 Jul. 17 [cited 2026 Apr. 3];2(3). Available from: https://www.jmhsr.info/index.php/jmhsr/article/view/457